In the last trading session, 2.36 million Vigil Neuroscience Inc (NASDAQ:VIGL) shares changed hands as the company’s beta touched 3.44. With the company’s per share price at $7.88 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $367.77M. VIGL’s last price was a discount, traded about -0.89% off its 52-week high of $7.95. The share price had its 52-week low at $1.31, which suggests the last value was 83.38% up since then. When we look at Vigil Neuroscience Inc’s average trading volume, we note the 10-day average is 1.51 million shares, with the 3-month average coming to 935.53K.
Analysts gave the Vigil Neuroscience Inc (VIGL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended VIGL as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
The company’s shares are showing year-to-date upside of 363.53%, with the 5-day performance at -0.63% in the red. However, in the 30-day time frame, Vigil Neuroscience Inc (NASDAQ:VIGL) is 226.97% up. Looking at the short shares, we see there were 0.4 million shares sold at short interest cover period of 2.78 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 1.5% from its current market value. According to analyst projections, VIGL’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -1.52% plunge from its current level, while the stock would need to soar -1.52% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -19.68%. The 2025 estimates are for Vigil Neuroscience Inc earnings to increase by 11.29%, but the outlook for the next 5-year period is at 8.10% per year.
VIGL Dividends
Vigil Neuroscience Inc is expected to release its next quarterly earnings report on 2025-May-06.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 18.17% of Vigil Neuroscience Inc shares while 79.64% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 97.33%. There are 79.64% institutions holding the Vigil Neuroscience Inc stock share, with ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC the top institutional holder. As of 2024-06-30, the company held 14.6419% of the shares, roughly 5.84 million VIGL shares worth $23.35 million.
NORTHPOND VENTURES, LLC holds the second largest percentage of outstanding shares, with 10.5722% or 4.21 million shares worth $16.86 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were abrdn Life Sciences Investors and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 1.66 shares estimated at $13.07 million under it, the former controlled 3.55% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 1.52% of the shares, roughly 710.14 shares worth around $5.6 million.
